U.S. Reports 147K New Covid Cases, 397 Deaths

uscoronavirus july29 lt

With 147,362 new positive cases reported on Thursday, the total number of people that have been infected with the coronavirus in the United States has risen to 91,124,591, as per Johns Hopkins University's latest data.

397 additional deaths on the same day took total U.S. Covid casualties to 1,029,285.

Ohio reported the most number of new cases - 29,876 - and deaths - 54.

Covid deaths have increased by 4 percent, while cases increased by 2 percent in the last two weeks, New York Times' latest tally shows.

More than 43,000 people are currently in American hospitals with the coronavirus, an increase of 11 percent over the last two weeks. More than 5,000 of these patients are admitted in intensive care units, marking a 13 percent rise in a fortnight.

87,908,049 people have so far recovered from the disease, the Worldometer tally shows.

As per the latest data published by the Centers for Disease Control and Prevention, 223,245,563 Americans, or 67.2 percent of the eligible population, have been administered both doses of Covid vaccine so far. This includes 91.9 percent of people above 65.

48.3 percent of the eligible population, or 107,924,198 people, have already received a booster dose that is recommended to provide additional protection from the killer virus.

2,488 additional deaths were reported globally on Thursday, taking the total number of people who lost their lives due to the pandemic so far to 6,395,829.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
Follow RTT